Stephen Proctor
Impact in
-
- Viral-associated cancers and disorders
- Polyomavirus and related diseases
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment
Papers in
-
- Ubiquitin and proteasome pathways 1
- Genetics 3
- Chronic Lymphocytic Leukemia Research 3
- Diabetes and associated disorders 1
- Co-authors
- Arezki Boudaoud (1 shared paper)Fred Chang (1 shared paper)Nicolas Minc (1 shared paper)Penny Taylor (2 shared papers)Ruth F. Jarrett (2 shared papers)Alice Gallagher (2 shared papers)Lesley Shield (2 shared papers)G. B. Clements (2 shared papers)
- Journals
- International Journal of Oncology (2 papers)International Journal of Cancer (2 papers)ACS Central Science (2 papers)Current Biology (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Stephen Proctor
10 papers receiving 371 citations
Peers
Comparison fields: 5 of 58
- Oncology 163
- Pathology and Forensic Medicine 99
- Hematology 50
- Cell Biology 60
- Molecular Biology 150
Countries citing papers authored by Stephen Proctor
This map shows the geographic impact of Stephen Proctor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Proctor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Proctor more than expected).
Fields of papers citing papers by Stephen Proctor
This network shows the impact of papers produced by Stephen Proctor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Proctor. The network helps show where Stephen Proctor may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephen Proctor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 155 | |
| 2 | 2012 | 110 | |
| 3 | 1994 | 46 | |
| 4 | 1985 | 31 | |
| 5 | 2008 | 10 | |
| 6 | 2022 | 7 | |
| 7 | 1999 | 6 | |
| 8 | 2008 | 5 | |
| 9 | 2003 | 4 | |
| 10 | 2000 | 3 | |
| 11 | 2025 | 0 | |
| 12 | Understanding positive employee attitudes to organizational change: the emergence and impact of ‘actor presence’ | 2016 | 0 |
About Stephen Proctor
Stephen Proctor is a scholar working on Molecular Biology, Genetics, Pathology and Forensic Medicine, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 12 papers that have together received 377 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Viral-associated cancers and disorders (2 papers), Nuclear Materials and Properties (1 paper), Ubiquitin and proteasome pathways (1 paper), Acute Lymphoblastic Leukemia research (1 paper), Bioactive Compounds and Antitumor Agents (1 paper) and Diabetes and associated disorders (1 paper). The work is most often cited by research in Oncology (163 citations), Pathology and Forensic Medicine (99 citations), Hematology (50 citations), Cell Biology (60 citations) and Molecular Biology (150 citations). Stephen Proctor has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Arezki Boudaoud, Fred Chang, Nicolas Minc, Penny Taylor, Ruth F. Jarrett, Alice Gallagher, Lesley Shield, G. B. Clements, Gulfaraz Khan and Annette Lake. Their work appears in journals such as International Journal of Oncology, International Journal of Cancer, ACS Central Science, Current Biology and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.